Expression of Fyn kinase modulates EMT in oral cancer cells

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2591-2596

  Lewin, Ben ^a   Siu, Amanda ^a   Baker, Cameron ^a   Dang, Dongmin ^a   Schnitt, Rebecca ^a   Eisapooran, Pedram ^a   Ramos, Daniel M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

6; EMT; Fyn kinase; Integrin; Oral SCC; Serum

Indexed keywords

BIOLOGICAL MARKER; GROWTH FACTOR; PROTEIN KINASE FYN;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MOUTH CANCER; MOUTH MUCOSA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL MOVEMENT; CULTURE MEDIA; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; KERATINS; MESODERM; MICROSCOPY, FLUORESCENCE; MOUTH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-FYN; SERUM; SIGNAL TRANSDUCTION;

EID: 77955827717     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Silverman SJ: Oral Cancer. Ontario: B C Decker, 1998.
2. Ramos DM, Chen BL, Boylen KB, Stern M, Kramer RH, Sheppard D, Nishimura SL, Greenspan DG, Zardi L and Pytela R: Stromal fibroblasts influence oral squamous cell carcinoma cell's interactions with tenascin-C. Int J of Cancer 72: 369-372, 1997.
3. Ramos DM, Chen B L, Regezi J, Zardi L and Pytela R: Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J of Cancer 75: 680-687, 1998. (Pubitemid 28145813)
4. Ramos DM, Dang D and Sadler S: The role of the integrin alpha ν beta 6 in regulating epithelial to mesenchymal transition in oral cancer. Anticancer Res 29: 3-8, 2009.
5. Li X, Yang Y, Hu Y, Dang D, Regezi J, Schmidt BL, Atakilit A, Chen B, Ellis D, and Ramos DM: Alpha ν beta 6-Fyn signaling promotes oral cancer progression. J Biol Chem 278: 41646-41653, 2003.
6. Ramos DM, Wu T, Schmidt B, But M, Regezi J, Jordon R, Atakilit A and Li X: Expression of the integrin ανβ6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biology 21: 297-307, 2002. (Pubitemid 34497020)
7. Sheppard D: Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 3: 395-402, 2005. (Pubitemid 41569979)
8. Hazelbag S, Kenter GG, Gorter A, Dreef EJ, Koopman LA, Violette SM, Weinreb PH and Fleuren GJ: Overexpression of the alpha ν beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol 3: 316-324, 2007. (Pubitemid 47010065)
9. Bates RC: Colorectal cancer progression: integrin alpha ν beta 6 and the epithelial-mesenchymal transition (EMT). Cell Cycle 4: 1350-1352, 2005.
10. Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D, Kren A, Went P, Derksen PW, Berns A, Jonkers J and Christofori G: NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 27: 2603-2615, 2008.
11. Pećina-Slaus N: Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int. Oct 14;3(1): 1-7; 2003.